Office of the Director

226.2k citations
4.0k papers ·

Impact in

  • Oncology top 5%
    • CAR-T cell therapy research
    • Drug Transport and Resistance Mechanisms
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology

Papers in

Office of the Director

3.5k papers receiving 193.6k citations

Peers

Office of the Director
Comparison fields: 5 of 246
  • Oncology 31.3k
  • Immunology 23.4k
  • Cancer Research 11.9k
  • Molecular Biology 52.2k
  • Epidemiology 23.5k
Replace Center for Drug Evaluation and Research with:
Center for Drug Evaluation and Research United States
Johns Hopkins Bayview Medical Center United States
University of Maryland Medical Center United States
Eastern Virginia Medical School United States
American Red Cross United States
Children's National United States
Janssen (United States) United States
Johnson & Johnson (United States) United States
University of Virginia Health System United States
Durham VA Medical Center United States
Office of the Director relative to Center for Drug Evaluation and Research United States Center for Drug Evaluation and Research's profile →
Citations per field
00.5×1.5×
Center for Drug Evaluation and Research · 1×
Citations per year

Countries citing scholars working at Office of the Director

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Office of the Director. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Office of the Director with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Office of the Director more than expected).

Fields of papers published by authors at Office of the Director

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Office of the Director at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Office of the Director at the time of their publication.

About Office of the Director

In recent decades, authors affiliated with Office of the Director have published 4.0k papers, which have received a total of 226.2k indexed citations . Scholars at this organization have produced 468 papers in Public Health, Environmental and Occupational Health, 416 papers in Oncology, 295 papers in Immunology, 66 papers in Virology and 221 papers in Infectious Diseases on the topics of Immune Cell Function and Interaction (103 papers), Monoclonal and Polyclonal Antibodies Research (88 papers), Health and Medical Research Impacts (85 papers), Immunotherapy and Immune Responses (75 papers), T-cell and B-cell Immunology (71 papers), Sex and Gender in Healthcare (66 papers), Health Systems, Economic Evaluations, Quality of Life (61 papers) and Ethics in Clinical Research (60 papers). Their work is cited by papers focused on Oncology (31.3k citations), Immunology (23.4k citations), Cancer Research (11.9k citations), Molecular Biology (52.2k citations) and Epidemiology (23.5k citations). Authors at Office of the Director collaborate with scholars in United States, United Kingdom and Canada and have published in prestigious journals including Cancer, The Journal of Immunology, Journal of Biological Chemistry, The Lancet and Blood. Some of Office of the Director's most productive authors include Francis S. Collins, HAROLD E. VARMUS, Michael M. Gottesman, Susan E. Bates, Tito Fojo, Janine A. Clayton, Anthony S. Fauci, Julia Howe Rowland, Gopal K. Singh and Elias A. Zerhouni.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact